Navigation

Aimedic MMT

Bando Chemical Begins Sales of Absorbable Bone Regeneration Material

on April 7, 2023 in Industry, Innovation

Bando subsidiary Aimedic MMT has launched on April 1 an absorbable bone regeneration material marketed as e=Bone. The material uses the results of a research project for the development of artificial bones in industry-academia collaboration with the Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, and the Department of Materials Production Science, Osaka University Graduate School of Engineering....

Please subscribe to read the full story.Subscribe
Already a member? Log in here
Continue Reading

Bando Chemical Sets Sights on Expansion in Medical Equipment Business

on May 31, 2019 in Products

Belt manufacturer Bando Chemical Industries Ltd. (TYO:5195) is focusing on growing its business for medical and health care equipment – a sector where demand is expected to grow going forward. As part of this approach, the company recently spent 10.55 billion yen ($96.48 million) on acquiring Aimedic MMT Co. Ltd., which handles production, sales and afterservice for plastic surgery equipment....

Please subscribe to read the full story.Subscribe
Already a member? Log in here
Continue Reading

Bando Chemical to Bolster Medical Device Business With Acquisition of Aimedic MMT

on April 18, 2019 in Industry

Bando Chemical Industries Ltd. (TYO:5195) announced on April 5 that it signed a share purchase agreement to acquire all shares of Aimedic MMT Co. Ltd., a manufacturer, seller and provider of after-sale services for orthopedic medical devices. Acquired from a fund managed by the Polaris Capital Group Co. Ltd. for around 10.55 billion yen ($94.23 million), Aimedic MMT will become...

Please subscribe to read the full story.Subscribe
Already a member? Log in here
Continue Reading